tiprankstipranks
Advertisement
Advertisement

DE:ECQ0 Stock Latest News

Neurizon Sets April 2026 Expiry for NUZOA Listed Options
Company AnnouncementsNeurizon Sets April 2026 Expiry for NUZOA Listed Options
5d ago
Neurizon to Present NUZ-001 Science in HEALEY ALS Platform Trial Webinar
PremiumCompany Announcements
Neurizon to Present NUZ-001 Science in HEALEY ALS Platform Trial Webinar
5d ago
Neurizon Issues Director Shares, Affirms Compliance and Transparency
PremiumCompany Announcements
Neurizon Issues Director Shares, Affirms Compliance and Transparency
6d ago
Neurizon Therapeutics Seeks ASX Quotation for 9.5 Million New Shares
PremiumCompany Announcements
Neurizon Therapeutics Seeks ASX Quotation for 9.5 Million New Shares
6d ago
Neurizon CEO Michael Thurn Resigns as Biotech Launches Global Search for Successor
PremiumCompany Announcements
Neurizon CEO Michael Thurn Resigns as Biotech Launches Global Search for Successor
9d ago
Neurizon Expands NUZ-001 Huntington’s Disease Data at ASENT 2026
PremiumCompany AnnouncementsNeurizon Expands NUZ-001 Huntington’s Disease Data at ASENT 2026
20d ago
Neurizon Therapeutics Options Lapse, Trimming Potential Equity Overhang
Premium
Company Announcements
Neurizon Therapeutics Options Lapse, Trimming Potential Equity Overhang
21d ago
Neurizon Draws First $5m Tranche to Advance ALS Drug Trial
Premium
Company Announcements
Neurizon Draws First $5m Tranche to Advance ALS Drug Trial
26d ago
Neurizon Taps A$5m in Convertible Note Funding From Obsidian
PremiumCompany Announcements
Neurizon Taps A$5m in Convertible Note Funding From Obsidian
26d ago
Neurizon issues 10m shares under convertible note, affirms compliance and disclosure
PremiumCompany Announcements
Neurizon issues 10m shares under convertible note, affirms compliance and disclosure
26d ago
Neurizon Begins Pivotal NUZ-001 Dosing in HEALEY ALS Platform Trial
PremiumCompany Announcements
Neurizon Begins Pivotal NUZ-001 Dosing in HEALEY ALS Platform Trial
27d ago
Neurizon Narrows Half-Year Loss as Other Income Jumps and Net Assets Strengthen
PremiumCompany Announcements
Neurizon Narrows Half-Year Loss as Other Income Jumps and Net Assets Strengthen
28d ago
Neurizon Publishes General Meeting Results and Enhances Investor Engagement
PremiumCompany AnnouncementsNeurizon Publishes General Meeting Results and Enhances Investor Engagement
1M ago
Neurizon Therapeutics Issues Heavily Qualified General Meeting Presentation
Premium
Company Announcements
Neurizon Therapeutics Issues Heavily Qualified General Meeting Presentation
1M ago
Neurizon Therapeutics Director Marcus Hughes Increases Shareholding
Premium
Company Announcements
Neurizon Therapeutics Director Marcus Hughes Increases Shareholding
2M ago
Neurizon Secures FDA Green Light and Full Funding for Late-Stage NUZ-001 ALS Trial
PremiumCompany Announcements
Neurizon Secures FDA Green Light and Full Funding for Late-Stage NUZ-001 ALS Trial
2M ago
Neurizon Secures A$6m R&D Tax Rebate to Fund HEALEY ALS Trial
PremiumCompany Announcements
Neurizon Secures A$6m R&D Tax Rebate to Fund HEALEY ALS Trial
2M ago
Neurizon Therapeutics Seeks ASX Quotation for 73.5 Million New Shares
PremiumCompany Announcements
Neurizon Therapeutics Seeks ASX Quotation for 73.5 Million New Shares
2M ago
Neurizon Raises $5.9m in Entitlement Offer to Advance ALS Trial
PremiumCompany Announcements
Neurizon Raises $5.9m in Entitlement Offer to Advance ALS Trial
2M ago
Neurizon Therapeutics Updates Market on Director Michael Thurn’s Revised Securities Holdings
PremiumCompany AnnouncementsNeurizon Therapeutics Updates Market on Director Michael Thurn’s Revised Securities Holdings
2M ago
Neurizon Calls Virtual-Only General Meeting as It Shifts to Digital Shareholder Communications
Premium
Company Announcements
Neurizon Calls Virtual-Only General Meeting as It Shifts to Digital Shareholder Communications
2M ago
Neurizon Locks In Global Trademark Protection for NEURIZON Brand Across Key Pharma Markets
Premium
Company Announcements
Neurizon Locks In Global Trademark Protection for NEURIZON Brand Across Key Pharma Markets
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >